首页 > 最新文献

Transactions of The Royal Society of Tropical Medicine and Hygiene最新文献

英文 中文
'We no longer experience the same pain': a cross-sectional study assessing the impact of Heart and Sole Africa's podoconiosis prevention education program. 我们不再经历同样的痛苦":一项横断面研究,评估非洲心与足的足癣预防教育计划的影响。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-05 DOI: 10.1093/trstmh/trae007
Agazi Fitsum Gebreselassie, Natnael Shimelash, Ahamed Kallon, George Mkondo, Tonya Huston, Janna M Schurer

Background: Podoconiosis is a non-infectious neglected tropical disease caused by long-term exposure to irritant volcanic soils. It results in severe physical, psychological and financial consequences. Heart and Sole Africa (HASA) is a non-governmental, community-based organization providing management to podoconiosis patients in Rwanda. We sought to analyze the impact of their program on the lives of patients.

Methods: Quantitative surveys recorded the participants' demographics, adherence to HASA's management recommendations and changes in quality of life (QOL). Qualitative questions were used to gather respondent perspectives on HASA programming.

Results: We interviewed 127 patients from HASA's Musanze (n=47) and Burera (n=80) clinics. Almost all participants (98.4%) reported statistically significant (p<0.01) improvements in their QOL, and more than one-half (51.2%) had a favorable adherence score of >80%. Qualitative feedback identified specific challenges to adherence and recognition of program success in symptom management.

Conclusions: Our study demonstrated the value of community-based podoconiosis programming in improving the lives of patients. Practices such as regular feet washing, emollient application, shoe wearing and limb raising can result in a marked reduction of morbidity. Our findings support the argument for scaling up these management practices across Rwanda.

背景:足癣是一种被忽视的非传染性热带疾病,由长期暴露于刺激性火山土壤引起。这种疾病会导致严重的身体、心理和经济后果。Heart and Sole Africa(HASA)是一个非政府组织,以社区为基础,为卢旺达的足癣患者提供治疗。我们试图分析他们的项目对患者生活的影响:定量调查记录了参与者的人口统计学特征、对 HASA 管理建议的遵守情况以及生活质量(QOL)的变化。定性问题用于收集受访者对 HASA 计划的看法:我们对来自 HASA Musanze(47 人)和 Burera(80 人)诊所的 127 名患者进行了访谈。几乎所有参与者(98.4%)都报告说,在统计意义上(P80%),他们都能坚持治疗。定性反馈确定了在症状管理方面坚持和认可项目成功所面临的具体挑战:我们的研究证明了基于社区的足癣防治计划在改善患者生活方面的价值。定期洗脚、涂润肤剂、穿鞋和抬高肢体等做法可显著降低发病率。我们的研究结果支持在卢旺达全国推广这些管理方法的论点。
{"title":"'We no longer experience the same pain': a cross-sectional study assessing the impact of Heart and Sole Africa's podoconiosis prevention education program.","authors":"Agazi Fitsum Gebreselassie, Natnael Shimelash, Ahamed Kallon, George Mkondo, Tonya Huston, Janna M Schurer","doi":"10.1093/trstmh/trae007","DOIUrl":"10.1093/trstmh/trae007","url":null,"abstract":"<p><strong>Background: </strong>Podoconiosis is a non-infectious neglected tropical disease caused by long-term exposure to irritant volcanic soils. It results in severe physical, psychological and financial consequences. Heart and Sole Africa (HASA) is a non-governmental, community-based organization providing management to podoconiosis patients in Rwanda. We sought to analyze the impact of their program on the lives of patients.</p><p><strong>Methods: </strong>Quantitative surveys recorded the participants' demographics, adherence to HASA's management recommendations and changes in quality of life (QOL). Qualitative questions were used to gather respondent perspectives on HASA programming.</p><p><strong>Results: </strong>We interviewed 127 patients from HASA's Musanze (n=47) and Burera (n=80) clinics. Almost all participants (98.4%) reported statistically significant (p<0.01) improvements in their QOL, and more than one-half (51.2%) had a favorable adherence score of >80%. Qualitative feedback identified specific challenges to adherence and recognition of program success in symptom management.</p><p><strong>Conclusions: </strong>Our study demonstrated the value of community-based podoconiosis programming in improving the lives of patients. Practices such as regular feet washing, emollient application, shoe wearing and limb raising can result in a marked reduction of morbidity. Our findings support the argument for scaling up these management practices across Rwanda.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal trends and space-time distribution of leprosy relapse in Brazil from 2001 to 2021. 2001 至 2021 年巴西麻风病复发的时间趋势和时空分布。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-05 DOI: 10.1093/trstmh/trae021
Reagan Nzundu Boigny, Kellyn Kessiene de Sousa Cavalcante, Caroline Mary Gurgel Dias Florencio, Paula Sacha Frota Nogueira, Ciro Martins Gomes, Carlos Henrique Alencar

Background: To analyse the temporal trends and spatiotemporal distribution of leprosy relapse in Brazil from 2001 to 2021.

Methods: An ecological study with a temporal trend approach and space-time analysis of leprosy relapse in Brazil was carried out with data from the Notifiable Diseases Information System.

Results: A total of 31 334 patients who experienced leprosy relapse were identified. The number of recurrent cases tended to increase throughout the study period, and this increase was significant among females and in almost all age groups, except for those <15, 50-59 and ≥70 y. Several clusters of high- and low-risk patients were identified across all regions with a heterogeneous distribution.

Conclusions: The burden of relapse showed an increasing trend in some groups and was distributed in all regions.

背景:分析巴西麻风病复发的时间趋势和时空分布:分析2001年至2021年巴西麻风病复发的时间趋势和时空分布:方法:利用应报告疾病信息系统的数据,对巴西麻风病复发的时间趋势和时空分析进行了生态学研究:结果:共发现 31 334 名麻风病复发患者。在整个研究期间,复发病例的数量呈上升趋势,女性和几乎所有年龄组(结论除外)的复发病例数量都有显著增加:复发负担在某些群体中呈上升趋势,并且分布在所有地区。
{"title":"Temporal trends and space-time distribution of leprosy relapse in Brazil from 2001 to 2021.","authors":"Reagan Nzundu Boigny, Kellyn Kessiene de Sousa Cavalcante, Caroline Mary Gurgel Dias Florencio, Paula Sacha Frota Nogueira, Ciro Martins Gomes, Carlos Henrique Alencar","doi":"10.1093/trstmh/trae021","DOIUrl":"10.1093/trstmh/trae021","url":null,"abstract":"<p><strong>Background: </strong>To analyse the temporal trends and spatiotemporal distribution of leprosy relapse in Brazil from 2001 to 2021.</p><p><strong>Methods: </strong>An ecological study with a temporal trend approach and space-time analysis of leprosy relapse in Brazil was carried out with data from the Notifiable Diseases Information System.</p><p><strong>Results: </strong>A total of 31 334 patients who experienced leprosy relapse were identified. The number of recurrent cases tended to increase throughout the study period, and this increase was significant among females and in almost all age groups, except for those <15, 50-59 and ≥70 y. Several clusters of high- and low-risk patients were identified across all regions with a heterogeneous distribution.</p><p><strong>Conclusions: </strong>The burden of relapse showed an increasing trend in some groups and was distributed in all regions.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19 pandemic impacted the activities of the Schistosomiasis Control Program in Brazil: is the goal of controlling the disease by 2030 at risk? COVID-19 大流行对巴西血吸虫病控制计划活动的影响:到 2030 年控制该疾病的目标是否面临风险?
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-05 DOI: 10.1093/trstmh/trae024
Lucas Almeida Andrade, Wandklebson Silva da Paz, Rosália E Santos Ramos, Welde N Borges de Santana, Thuelly Juvêncio da Rocha, Flávia Silva Damasceno, Allan Dantas Dos Santos, Débora Dos Santos Tavares, Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza, Deborah Aparecida Negrão-Corrêa, Ricardo Toshio Fujiwara, Abelardo Silva-Júnior, Wagnner José Nascimento Porto, Márcio Bezerra-Santos

Background: Schistosomiasis continues to represent a serious public health problem in Brazil. With the coronavirus disease 2019 (COVID-19) pandemic, several control strategies were suspended, probably compromising the goals of eradicating the disease in the country. We aimed to assess the impact of the COVID-19 pandemic on Schistosomiasis Control Program (PCE) actions in all endemic states of Brazil.

Methods: We performed an ecological study using spatial analysis techniques. The PCE variables assessed were the population surveyed, the number of Kato-Katz tests, positive cases of schistosomiasis and the percentage of cases treated between 2015 and 2021. The percent change was calculated to verify if there was an increase or decrease in 2020 and 2021, along with time trend analyses provided by the Joinpoint model. Spatial distribution maps were elaborated considering the percent change.

Results: The surveyed population decreased in 2020 (-65.38%) and 2021 (-37.94%) across Brazil. There was a proportional reduction in the number of Kato-Katz tests (2020, -67.48%; 2021, -40.52%), a decrease in the percentage of positive cases (2020, -71.16%; 2021, -40.5%) and a reduction in the percentage of treated cases (2020, -72.09%; 2021, -41.67%). Time trend analyses showed a decreasing trend in most PCE variables.

Conclusions: The PCE activities were impacted by the COVID-19 pandemic in Brazil and PCE strategies must be urgently reviewed, focusing on investments in all endemic areas.

背景:血吸虫病仍然是巴西的一个严重公共卫生问题。随着 2019 年冠状病毒病(COVID-19)的流行,一些控制策略被暂停,这可能会影响在巴西根除该疾病的目标。我们旨在评估 COVID-19 大流行对巴西所有流行州血吸虫病控制计划(PCE)行动的影响:我们利用空间分析技术开展了一项生态研究。所评估的 PCE 变量包括 2015 年至 2021 年间调查的人口、卡托-卡茨检测次数、血吸虫病阳性病例以及治疗病例的百分比。计算了变化百分比,以核实 2020 年和 2021 年是增加还是减少,同时利用 Joinpoint 模型提供的时间趋势分析。根据变化百分比绘制了空间分布图:巴西全国的调查人口在 2020 年(-65.38%)和 2021 年(-37.94%)有所减少。卡托-卡茨检测的数量成比例减少(2020 年,-67.48%;2021 年,-40.52%),阳性病例的百分比下降(2020 年,-71.16%;2021 年,-40.5%),治疗病例的百分比下降(2020 年,-72.09%;2021 年,-41.67%)。时间趋势分析表明,大多数 PCE 变量呈下降趋势:巴西的 PCE 活动受到了 COVID-19 大流行的影响,必须立即对 PCE 战略进行审查,重点关注对所有流行地区的投资。
{"title":"The COVID-19 pandemic impacted the activities of the Schistosomiasis Control Program in Brazil: is the goal of controlling the disease by 2030 at risk?","authors":"Lucas Almeida Andrade, Wandklebson Silva da Paz, Rosália E Santos Ramos, Welde N Borges de Santana, Thuelly Juvêncio da Rocha, Flávia Silva Damasceno, Allan Dantas Dos Santos, Débora Dos Santos Tavares, Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza, Deborah Aparecida Negrão-Corrêa, Ricardo Toshio Fujiwara, Abelardo Silva-Júnior, Wagnner José Nascimento Porto, Márcio Bezerra-Santos","doi":"10.1093/trstmh/trae024","DOIUrl":"10.1093/trstmh/trae024","url":null,"abstract":"<p><strong>Background: </strong>Schistosomiasis continues to represent a serious public health problem in Brazil. With the coronavirus disease 2019 (COVID-19) pandemic, several control strategies were suspended, probably compromising the goals of eradicating the disease in the country. We aimed to assess the impact of the COVID-19 pandemic on Schistosomiasis Control Program (PCE) actions in all endemic states of Brazil.</p><p><strong>Methods: </strong>We performed an ecological study using spatial analysis techniques. The PCE variables assessed were the population surveyed, the number of Kato-Katz tests, positive cases of schistosomiasis and the percentage of cases treated between 2015 and 2021. The percent change was calculated to verify if there was an increase or decrease in 2020 and 2021, along with time trend analyses provided by the Joinpoint model. Spatial distribution maps were elaborated considering the percent change.</p><p><strong>Results: </strong>The surveyed population decreased in 2020 (-65.38%) and 2021 (-37.94%) across Brazil. There was a proportional reduction in the number of Kato-Katz tests (2020, -67.48%; 2021, -40.52%), a decrease in the percentage of positive cases (2020, -71.16%; 2021, -40.5%) and a reduction in the percentage of treated cases (2020, -72.09%; 2021, -41.67%). Time trend analyses showed a decreasing trend in most PCE variables.</p><p><strong>Conclusions: </strong>The PCE activities were impacted by the COVID-19 pandemic in Brazil and PCE strategies must be urgently reviewed, focusing on investments in all endemic areas.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140923436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the impact of severe acute respiratory syndrome coronavirus 2 infection on hematological parameters. 评估严重急性呼吸系统综合征冠状病毒 2 感染对血液学参数的影响。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-31 DOI: 10.1093/trstmh/trae047
Badi A Alotaibi, Jehad A Aldali, Hamzah J Aldali, Ali Alaseem, Abdulaziz M Almuqrin, Abdulrahman Alshalani, Hamood AlSudais, Nasser A Alshehri, Nasser B Alamar, Mogtba A Alhejji

Background: The current study is a retrospective study designed to evaluate changes in complete blood count and coagulation parameters in adult coronavirus disease 2019 (COVID-19) patients at a prominent Saudi tertiary center to predict disease severity and mortality.

Methods: The cohort consisted of 74 800 adult patients divided into four groups based on a COVID-19 test and the patient's sex: 35 985 in the female negative COVID-19 group, 23 278 in the male negative COVID-19 group, 8846 in the female positive COVID-19 group and 6691 in the male positive COVID-19 group.

Results: Patients with COVID-19 demonstrated decreased white blood cell counts and increased red blood cell counts. Also, COVID-19-positive participants exhibited more prolonged partial thromboplastin time and lower D-dimer levels than those of COVID-19-negative subjects (p<0.05). The study also revealed gender-dependent impacts on platelet counts, implying a possible relationship with the greater infection mortality rate in men than in women (p<0.001). In addition, the study found a link between changes in coagulation test results and death in COVID-19 patients (p<0.001). The evidence regarding the effects of COVID-19 on blood cell counts and coagulation, on the other hand, is conflicting, most likely due to variances in study populations and the timing of testing postinfection.

Conclusions: According to the findings, COVID-19-related alterations in blood cell count and clotting ability may be risk factors for death.

研究背景本研究是一项回顾性研究,旨在评估沙特一家著名的三级中心2019年冠状病毒病(COVID-19)成人患者全血细胞计数和凝血参数的变化,以预测疾病的严重程度和死亡率:研究对象包括74 800名成年患者,根据COVID-19检测结果和患者性别分为四组:女性COVID-19阴性组35 985人,男性COVID-19阴性组23 278人,女性COVID-19阳性组8846人,男性COVID-19阳性组6691人:结果:COVID-19 患者的白细胞计数减少,红细胞计数增加。此外,与 COVID-19 阴性受试者相比,COVID-19 阳性受试者的部分凝血活酶时间更长,D-二聚体水平更低:根据研究结果,与 COVID-19 相关的血细胞计数和凝血能力的改变可能是导致死亡的风险因素。
{"title":"Assessing the impact of severe acute respiratory syndrome coronavirus 2 infection on hematological parameters.","authors":"Badi A Alotaibi, Jehad A Aldali, Hamzah J Aldali, Ali Alaseem, Abdulaziz M Almuqrin, Abdulrahman Alshalani, Hamood AlSudais, Nasser A Alshehri, Nasser B Alamar, Mogtba A Alhejji","doi":"10.1093/trstmh/trae047","DOIUrl":"https://doi.org/10.1093/trstmh/trae047","url":null,"abstract":"<p><strong>Background: </strong>The current study is a retrospective study designed to evaluate changes in complete blood count and coagulation parameters in adult coronavirus disease 2019 (COVID-19) patients at a prominent Saudi tertiary center to predict disease severity and mortality.</p><p><strong>Methods: </strong>The cohort consisted of 74 800 adult patients divided into four groups based on a COVID-19 test and the patient's sex: 35 985 in the female negative COVID-19 group, 23 278 in the male negative COVID-19 group, 8846 in the female positive COVID-19 group and 6691 in the male positive COVID-19 group.</p><p><strong>Results: </strong>Patients with COVID-19 demonstrated decreased white blood cell counts and increased red blood cell counts. Also, COVID-19-positive participants exhibited more prolonged partial thromboplastin time and lower D-dimer levels than those of COVID-19-negative subjects (p<0.05). The study also revealed gender-dependent impacts on platelet counts, implying a possible relationship with the greater infection mortality rate in men than in women (p<0.001). In addition, the study found a link between changes in coagulation test results and death in COVID-19 patients (p<0.001). The evidence regarding the effects of COVID-19 on blood cell counts and coagulation, on the other hand, is conflicting, most likely due to variances in study populations and the timing of testing postinfection.</p><p><strong>Conclusions: </strong>According to the findings, COVID-19-related alterations in blood cell count and clotting ability may be risk factors for death.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trust in institutions affects vaccination campaign outcomes. 对机构的信任会影响疫苗接种活动的结果。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-30 DOI: 10.1093/trstmh/trae048
David Leblang, Michael D Smith, Dennis Wesselbaum

Background: Trust is an important driver of various outcomes, but little is known about whether trust in institutions affects actual vaccination campaign outcomes rather than only beliefs and intentions.

Methods: We used nationally representative, individual-level data for 114 countries and combined them with data on vaccination policies and rates. We measured the speed of the vaccination campaign for each country using the estimated growth rate of a Gompertz curve. We then performed country-level regressions in the global sample and explored heterogeneity across World Bank development groups.

Results: Globally, higher trust in institutions significantly increased vaccination rates (p<0.01) and vaccination speed (p<0.01). The effect was strong in low- and middle-income countries but statistically not significant in high-income countries.

Conclusions: Our findings have implications for the design of vaccination campaigns for national governments and international organizations. The findings highlight the importance of trust in institutions when designing communication strategies around vaccination campaigns in low- and middle-income countries.

背景:信任是各种结果的重要驱动因素,但人们对机构信任是否会影响疫苗接种活动的实际结果而不仅仅是信念和意向知之甚少:我们使用了 114 个国家具有全国代表性的个人层面数据,并将其与疫苗接种政策和接种率数据相结合。我们使用贡培兹曲线的估计增长率来衡量每个国家的疫苗接种活动速度。然后,我们在全球样本中进行了国家级回归,并探讨了世界银行各发展集团之间的异质性:结果:在全球范围内,机构信任度越高,疫苗接种率越高(p):我们的研究结果对各国政府和国际组织设计疫苗接种活动具有启示意义。研究结果强调了在中低收入国家围绕疫苗接种活动设计传播策略时对机构信任的重要性。
{"title":"Trust in institutions affects vaccination campaign outcomes.","authors":"David Leblang, Michael D Smith, Dennis Wesselbaum","doi":"10.1093/trstmh/trae048","DOIUrl":"https://doi.org/10.1093/trstmh/trae048","url":null,"abstract":"<p><strong>Background: </strong>Trust is an important driver of various outcomes, but little is known about whether trust in institutions affects actual vaccination campaign outcomes rather than only beliefs and intentions.</p><p><strong>Methods: </strong>We used nationally representative, individual-level data for 114 countries and combined them with data on vaccination policies and rates. We measured the speed of the vaccination campaign for each country using the estimated growth rate of a Gompertz curve. We then performed country-level regressions in the global sample and explored heterogeneity across World Bank development groups.</p><p><strong>Results: </strong>Globally, higher trust in institutions significantly increased vaccination rates (p<0.01) and vaccination speed (p<0.01). The effect was strong in low- and middle-income countries but statistically not significant in high-income countries.</p><p><strong>Conclusions: </strong>Our findings have implications for the design of vaccination campaigns for national governments and international organizations. The findings highlight the importance of trust in institutions when designing communication strategies around vaccination campaigns in low- and middle-income countries.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infections following rattlesnake envenomation and use of antibiotics. 响尾蛇中毒后的感染和抗生素的使用。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-29 DOI: 10.1093/trstmh/trae044
Stephen A Klotz, Geoffrey T Smelski, Sarah A Watkins, F Mazda Shirazi

Background: There are 7000-8000 venomous snake bites annually in the USA. Antibiotics are commonly administered to bite victims because infection is difficult to differentiate from local tissue injury following envenomation.

Methods: The Arizona Poison and Drug Information Center (APDIC) in Tucson oversees antivenom administration for 14 Arizona counties. Records (1999-2021) were searched for antibiotic use and confirmed infections after a rattlesnake bite.

Results: There were 4160 calls to APDIC regarding rattlesnakes. After excluding bites to animals, 'dry bites', prisoners and records with missing data, 2059 records were evaluated. Systemic antibiotics were administered to 206 patients (10% of bite victims). Twenty patients (0.97%) had confirmed infections, including cellulitis (n=10), fasciitis (n=4), abscess (n=3) and osteomyelitis (n=3). Five of the victims had positive blood cultures. The presence of tissue necrosis, leukocytosis, fever and elevated fibrinogen levels did not discriminate between toxic effects of venom and infection.

Conclusions: Confirmed infections following a rattlesnake bite are uncommon (0.97% of bites). Physicians should refrain from prescribing antibiotics, as they are not justified for most rattlesnake bite victims and the variety of pathogens encountered precludes use of any single effective antibiotic.

背景:在美国,每年有 7000-8000 人被毒蛇咬伤。由于毒蛇咬伤后很难区分感染和局部组织损伤,因此通常会给咬伤者注射抗生素:方法:位于图森的亚利桑那毒物和药物信息中心(APDIC)负责亚利桑那州 14 个县的抗蛇毒血清管理。对响尾蛇咬伤后使用抗生素和确诊感染的记录(1999-2021 年)进行了检索:APDIC 共接到 4160 个有关响尾蛇的电话。在排除动物咬伤、"干咬伤"、囚犯和数据缺失的记录后,共评估了 2059 条记录。206名患者(占咬伤患者的10%)接受了全身抗生素治疗。20名患者(0.97%)确诊感染,包括蜂窝组织炎(10人)、筋膜炎(4人)、脓肿(3人)和骨髓炎(3人)。其中五名受害者的血液培养呈阳性。组织坏死、白细胞增多、发烧和纤维蛋白原水平升高并不能区分毒液的毒性作用和感染:结论:响尾蛇咬伤后确诊感染的情况并不常见(占咬伤的 0.97%)。医生应避免开具抗生素处方,因为大多数响尾蛇咬伤患者都没有理由使用抗生素,而且所遇到的病原体种类繁多,无法使用任何一种有效的抗生素。
{"title":"Infections following rattlesnake envenomation and use of antibiotics.","authors":"Stephen A Klotz, Geoffrey T Smelski, Sarah A Watkins, F Mazda Shirazi","doi":"10.1093/trstmh/trae044","DOIUrl":"https://doi.org/10.1093/trstmh/trae044","url":null,"abstract":"<p><strong>Background: </strong>There are 7000-8000 venomous snake bites annually in the USA. Antibiotics are commonly administered to bite victims because infection is difficult to differentiate from local tissue injury following envenomation.</p><p><strong>Methods: </strong>The Arizona Poison and Drug Information Center (APDIC) in Tucson oversees antivenom administration for 14 Arizona counties. Records (1999-2021) were searched for antibiotic use and confirmed infections after a rattlesnake bite.</p><p><strong>Results: </strong>There were 4160 calls to APDIC regarding rattlesnakes. After excluding bites to animals, 'dry bites', prisoners and records with missing data, 2059 records were evaluated. Systemic antibiotics were administered to 206 patients (10% of bite victims). Twenty patients (0.97%) had confirmed infections, including cellulitis (n=10), fasciitis (n=4), abscess (n=3) and osteomyelitis (n=3). Five of the victims had positive blood cultures. The presence of tissue necrosis, leukocytosis, fever and elevated fibrinogen levels did not discriminate between toxic effects of venom and infection.</p><p><strong>Conclusions: </strong>Confirmed infections following a rattlesnake bite are uncommon (0.97% of bites). Physicians should refrain from prescribing antibiotics, as they are not justified for most rattlesnake bite victims and the variety of pathogens encountered precludes use of any single effective antibiotic.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia. 探索南美锥虫病的潜伏期:哥伦比亚队列中的潜伏期和决定因素。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-05 DOI: 10.1093/trstmh/trae004
Mario Javier Olivera, Lyda Muñoz

Background: Chagas disease has a varying latency period, the time between infection and onset of cardiac symptoms, due to multiple factors. This study seeks to identify and understand these factors to enhance our knowledge of the disease.

Methods: A retrospective follow-up study was conducted in Colombia on patients with indeterminate chronic Chagas disease. Medical files were examined to evaluate the disease latency time using time ratios (TRs) and the AFT Weibull model.

Results: The study followed 578 patients, of whom 309 (53.5%) developed cardiac disease, with a median latency period of 18.5 (95% CI 16 to 20) y for the cohort. Those with the TcISyl genotype (TR 0.72; 95% CI 0.61 to 0.80), individuals who lived 5-15 y (TR 0.80; 95% CI 0.67 to 0.95), 15-30 y (TR 0.63; 95% CI 0.53 to 0.74) or >30 y (vs 5 y) in areas with high disease prevalence had shorter latency periods. On the other hand, undergoing treatment increased the latency period (TR: 1.74; 95% CI 1.52 to 1.87).

Conclusions: The latency period of Chagas disease was found to be independently related to male gender, receipt of etiological treatment, length of time spent in an endemic area and the TcISyl genotype. The implications of these findings are discussed.

背景:南美锥虫病的潜伏期(从感染到出现心脏症状的时间)因多种因素而异。本研究旨在确定和了解这些因素,以增进我们对该疾病的了解:方法:在哥伦比亚对不确定的慢性南美锥虫病患者进行了一项回顾性随访研究。研究采用时间比率(TRs)和AFT Weibull模型对医疗档案进行检查,以评估疾病的潜伏时间:该研究跟踪了 578 名患者,其中 309 人(53.5%)罹患心脏疾病,中位潜伏期为 18.5 年(95% CI 16-20 年)。那些具有TcISyl基因型(TR 0.72;95% CI 0.61至0.80)、在疾病高发地区生活了5至15年(TR 0.80;95% CI 0.67至0.95)、15至30年(TR 0.63;95% CI 0.53至0.74)或超过30年(vs 5年)的人的潜伏期较短。另一方面,接受治疗会延长潜伏期(TR:1.74;95% CI 1.52 至 1.87):结论:研究发现恰加斯病的潜伏期与男性性别、接受病因治疗的时间、在流行地区居住的时间和 TcISyl 基因型无关。本文讨论了这些发现的意义。
{"title":"Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia.","authors":"Mario Javier Olivera, Lyda Muñoz","doi":"10.1093/trstmh/trae004","DOIUrl":"10.1093/trstmh/trae004","url":null,"abstract":"<p><strong>Background: </strong>Chagas disease has a varying latency period, the time between infection and onset of cardiac symptoms, due to multiple factors. This study seeks to identify and understand these factors to enhance our knowledge of the disease.</p><p><strong>Methods: </strong>A retrospective follow-up study was conducted in Colombia on patients with indeterminate chronic Chagas disease. Medical files were examined to evaluate the disease latency time using time ratios (TRs) and the AFT Weibull model.</p><p><strong>Results: </strong>The study followed 578 patients, of whom 309 (53.5%) developed cardiac disease, with a median latency period of 18.5 (95% CI 16 to 20) y for the cohort. Those with the TcISyl genotype (TR 0.72; 95% CI 0.61 to 0.80), individuals who lived 5-15 y (TR 0.80; 95% CI 0.67 to 0.95), 15-30 y (TR 0.63; 95% CI 0.53 to 0.74) or >30 y (vs 5 y) in areas with high disease prevalence had shorter latency periods. On the other hand, undergoing treatment increased the latency period (TR: 1.74; 95% CI 1.52 to 1.87).</p><p><strong>Conclusions: </strong>The latency period of Chagas disease was found to be independently related to male gender, receipt of etiological treatment, length of time spent in an endemic area and the TcISyl genotype. The implications of these findings are discussed.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial-temporal distribution of visceral leishmaniasis in Rio de Janeiro, Brazil, 2001-2020: expansion and challenges. 2001-2020 年巴西里约热内卢内脏利什曼病的时空分布:扩展与挑战。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-05 DOI: 10.1093/trstmh/trae009
Alex de O Vasconcelos, Sandro J Bedoya-Pacheco, Rafael R Cunha E Silva, Mônica de A F M Magalhães, Tayana P S O de Sá, Cristina M G Dias, Patrícia S Meneguete, Paula M P de Almeida, Maria Inês F Pimentel

Background: Visceral leishmaniasis results from complex interactions among humans, dogs and environment. Brazil accounts for 97% of cases in the Americas.

Methods: Twenty years (2001-2020) of the endemic disease in the state of Rio de Janeiro were studied. Incidence, lethality, sociodemographic and clinical characteristics were investigated, complemented with spatial methodologies (kernel and clusters).

Results: Ninety-seven human cases and 625 dogs were reported. Of the 92 cities, 22 were human endemic areas. The state had a low incidence level (0.6 per 100 000). Lethality was higher compared with the Brazilian average. More than 90% of infections occurred in urban areas. Most cases (66%) occurred in men. The predominant age groups were 0-4 y (28.7%) and 20-39 y (32.9%). Fever (89.5%), splenomegaly (83.2%) and hepatomegaly (76.8%) were the main clinical manifestations. Spatial analysis showed a displacement of the human endemic: in the first decade (2001-2010), cases were concentrated in the Metropolitan region, and in the second decade (2011-2020) in the Médio Paraíba region of the state. Most of the endemic area (56.4%) had canine infections without reported human cases.

Conclusions: Disorderly urbanisation and precarious living conditions favour the transmission of the disease. Changes in the environment and migratory processes contribute to its expansion.

背景:人、狗和环境之间复杂的相互作用导致了内脏利什曼病。巴西的病例占美洲病例的 97%:方法:对里约热内卢州 20 年(2001-2020 年)的地方病进行了研究。调查了发病率、致死率、社会人口和临床特征,并辅以空间方法(内核和群组):结果:共报告了 97 例人类病例和 625 条狗。在 92 个城市中,22 个是人类流行区。该州的发病率较低(0.6/100 000)。死亡率高于巴西的平均水平。90%以上的感染病例发生在城市地区。大多数病例(66%)发生在男性身上。主要年龄组为 0-4 岁(28.7%)和 20-39 岁(32.9%)。发热(89.5%)、脾脏肿大(83.2%)和肝脏肿大(76.8%)是主要的临床表现。空间分析显示了人类流行病的转移:在第一个十年(2001-2010 年),病例集中在大都会地区,而在第二个十年(2011-2020 年),病例集中在该州的梅迪奥帕拉伊巴地区。大部分流行区(56.4%)都有犬类感染病例,但没有人类病例报告:结论:无序的城市化和不稳定的生活条件有利于疾病的传播。环境的变化和迁徙过程助长了该疾病的蔓延。
{"title":"Spatial-temporal distribution of visceral leishmaniasis in Rio de Janeiro, Brazil, 2001-2020: expansion and challenges.","authors":"Alex de O Vasconcelos, Sandro J Bedoya-Pacheco, Rafael R Cunha E Silva, Mônica de A F M Magalhães, Tayana P S O de Sá, Cristina M G Dias, Patrícia S Meneguete, Paula M P de Almeida, Maria Inês F Pimentel","doi":"10.1093/trstmh/trae009","DOIUrl":"10.1093/trstmh/trae009","url":null,"abstract":"<p><strong>Background: </strong>Visceral leishmaniasis results from complex interactions among humans, dogs and environment. Brazil accounts for 97% of cases in the Americas.</p><p><strong>Methods: </strong>Twenty years (2001-2020) of the endemic disease in the state of Rio de Janeiro were studied. Incidence, lethality, sociodemographic and clinical characteristics were investigated, complemented with spatial methodologies (kernel and clusters).</p><p><strong>Results: </strong>Ninety-seven human cases and 625 dogs were reported. Of the 92 cities, 22 were human endemic areas. The state had a low incidence level (0.6 per 100 000). Lethality was higher compared with the Brazilian average. More than 90% of infections occurred in urban areas. Most cases (66%) occurred in men. The predominant age groups were 0-4 y (28.7%) and 20-39 y (32.9%). Fever (89.5%), splenomegaly (83.2%) and hepatomegaly (76.8%) were the main clinical manifestations. Spatial analysis showed a displacement of the human endemic: in the first decade (2001-2010), cases were concentrated in the Metropolitan region, and in the second decade (2011-2020) in the Médio Paraíba region of the state. Most of the endemic area (56.4%) had canine infections without reported human cases.</p><p><strong>Conclusions: </strong>Disorderly urbanisation and precarious living conditions favour the transmission of the disease. Changes in the environment and migratory processes contribute to its expansion.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motivation-opportunity-ability-behaviour of community members and program implementers towards mass drug administration for lymphatic filariasis elimination in India: a systematic review and implementation priority. 在印度,社区成员和计划实施者为消除淋巴丝虫病而大规模用药的动机-机会-能力-行为:系统回顾与实施重点。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-05 DOI: 10.1093/trstmh/trae008
Abhinav Sinha, Sumegha Mohapatra, Krushna Chandra Sahoo, Shubhashisha Mohanty, Banamber Sahoo, Sanghamitra Pati, Prakash Kumar Sahoo

Lymphatic filariasis (LF) is a significant public health issue in India. Despite 10-15 rounds of mass drug administration (MDA) in India, the global LF elimination target of 2030 appears challenging. To strengthen the program, community and provider perspectives on ways to bridge a gap in MDA are needed. Through the motivation-opportunity-ability-behaviour (MOAB) lens, we systematically reviewed the facilitators and barriers encountered in LF elimination in India. We followed Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. We searched PubMed, Embase, ProQuest and Google Scholar databases to explore factors related to MDA program implementation in India through 30 June 2021. We analysed the data using a thematic framework. We identified 576 studies; of these, 20 studies were included. This review revealed that the public health system for distributing MDA drugs in India created a better enabling environment, including zero out-of-pocket expenditure, door-step distribution of medicines and ample capacity-building training and follow-up. However, community members were unaware of the rationale for drug consumption, leading to a gap in drug distribution and consumption. Motivation is required among community members, which suggests capacity-building training for service providers to counsel the community.

淋巴丝虫病(LF)是印度的一个重大公共卫生问题。尽管印度已开展了 10-15 轮大规模药物治疗 (MDA),但 2030 年消除淋巴丝虫病的全球目标似乎仍具有挑战性。为了加强该计划,需要从社区和医疗服务提供者的角度来探讨如何弥补大规模给药的不足。通过动机-机会-能力-行为(MOAB)视角,我们系统地回顾了印度在消除 LF 过程中遇到的促进因素和障碍。我们遵循了《系统综述和元分析首选报告项目》指南。我们检索了 PubMed、Embase、ProQuest 和 Google Scholar 数据库,探讨了截至 2021 年 6 月 30 日印度实施 MDA 计划的相关因素。我们采用主题框架对数据进行了分析。我们确定了 576 项研究;其中 20 项研究被纳入。综述显示,印度用于分发 MDA 药物的公共卫生系统创造了一个较好的有利环境,包括零自付支出、上门分发药物以及充足的能力建设培训和后续行动。然而,社区成员并不了解药物消费的理由,导致药物分发和消费方面存在差距。社区成员需要有积极性,这就需要对服务提供者进行能力建设培训,为社区提供咨询。
{"title":"Motivation-opportunity-ability-behaviour of community members and program implementers towards mass drug administration for lymphatic filariasis elimination in India: a systematic review and implementation priority.","authors":"Abhinav Sinha, Sumegha Mohapatra, Krushna Chandra Sahoo, Shubhashisha Mohanty, Banamber Sahoo, Sanghamitra Pati, Prakash Kumar Sahoo","doi":"10.1093/trstmh/trae008","DOIUrl":"10.1093/trstmh/trae008","url":null,"abstract":"<p><p>Lymphatic filariasis (LF) is a significant public health issue in India. Despite 10-15 rounds of mass drug administration (MDA) in India, the global LF elimination target of 2030 appears challenging. To strengthen the program, community and provider perspectives on ways to bridge a gap in MDA are needed. Through the motivation-opportunity-ability-behaviour (MOAB) lens, we systematically reviewed the facilitators and barriers encountered in LF elimination in India. We followed Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. We searched PubMed, Embase, ProQuest and Google Scholar databases to explore factors related to MDA program implementation in India through 30 June 2021. We analysed the data using a thematic framework. We identified 576 studies; of these, 20 studies were included. This review revealed that the public health system for distributing MDA drugs in India created a better enabling environment, including zero out-of-pocket expenditure, door-step distribution of medicines and ample capacity-building training and follow-up. However, community members were unaware of the rationale for drug consumption, leading to a gap in drug distribution and consumption. Motivation is required among community members, which suggests capacity-building training for service providers to counsel the community.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial resistance genetic determinants and susceptibility profile of Pseudomonas aeruginosa isolated from clinical samples in a tertiary hospital in Ogun State, Nigeria. 从尼日利亚奥贡州一家三级医院的临床样本中分离出的铜绿假单胞菌的抗菌药耐药性基因决定因素和药敏性概况。
IF 1.9 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-05 DOI: 10.1093/trstmh/trae012
Oluwatoyin Olawunmi Adeyelu, Edidiong Nkiruka Essien, Valentine Adebote, Abraham Ajayi, Utibeima Udo Essiet, Adeyemi Isaac Adeleye, Stella Ifeanyi Smith

Background: Genetic determinants are known to promote antibiotic resistance through horizontal gene transfer.

Methods: We molecularly characterized integrons, plasmid replicon types and metallo-β-lactamase-encoding genes of 38 Pseudomonas aeruginosa strains isolated from clinical samples.

Results: The P. aeruginosa isolates displayed high resistance (97.4%) to β-lactams. Seventeen (44.74%) of them possessed plasmids. Of the 17 isolates that possessed plasmids, 11 (64.7%) of them harboured IncFIA plasmid replicon type, while 6 (35.3%), 5 (29.4%) and 5 (29.4%) were of the IncFIB, IncF and IncW types, respectively. The intI1 gene was detected in 19 (50%) of the isolates. The blaNDM-A, blaNDM-B and blaVIM genes were detected in 14 (35.9%), 4 (10.3%) and 5 (12.8%) of the isolates, respectively.

Conclusions: High resistance to β-lactams was observed among P. aeruginosa strains of clinical origin in this study. They possessed transmissible genetic elements indicating the potential for continuous dissemination, thus continuous surveillance is advocated.

背景方法:我们对从临床样本中分离出的 38 株铜绿假单胞菌的整合子、质粒复制子类型和金属-β-内酰胺酶编码基因进行了分子鉴定:我们对从临床样本中分离出的38株铜绿假单胞菌的整合子、质粒复制子类型和金属β-内酰胺酶编码基因进行了分子鉴定:结果:铜绿假单胞菌分离株对β-内酰胺类药物的耐药性较高(97.4%)。其中 17 株(44.74%)具有质粒。在 17 个具有质粒的分离物中,11 个(64.7%)具有 IncFIA 质粒复制子类型,6 个(35.3%)、5 个(29.4%)和 5 个(29.4%)分别具有 IncFIB、IncF 和 IncW 类型。在 19 个(50%)分离物中检测到 intI1 基因。在 14 个(35.9%)、4 个(10.3%)和 5 个(12.8%)分离物中分别检测到 blaNDM-A、blaNDM-B 和 blaVIM 基因:结论:本研究观察到临床来源的铜绿假单胞菌菌株对β-内酰胺类药物具有高度耐药性。结论:本研究观察到临床来源的铜绿假单胞菌株对β-内酰胺类药物有很高的耐药性,它们具有可传播的遗传因子,表明有持续传播的潜力,因此建议进行持续监测。
{"title":"Antimicrobial resistance genetic determinants and susceptibility profile of Pseudomonas aeruginosa isolated from clinical samples in a tertiary hospital in Ogun State, Nigeria.","authors":"Oluwatoyin Olawunmi Adeyelu, Edidiong Nkiruka Essien, Valentine Adebote, Abraham Ajayi, Utibeima Udo Essiet, Adeyemi Isaac Adeleye, Stella Ifeanyi Smith","doi":"10.1093/trstmh/trae012","DOIUrl":"10.1093/trstmh/trae012","url":null,"abstract":"<p><strong>Background: </strong>Genetic determinants are known to promote antibiotic resistance through horizontal gene transfer.</p><p><strong>Methods: </strong>We molecularly characterized integrons, plasmid replicon types and metallo-β-lactamase-encoding genes of 38 Pseudomonas aeruginosa strains isolated from clinical samples.</p><p><strong>Results: </strong>The P. aeruginosa isolates displayed high resistance (97.4%) to β-lactams. Seventeen (44.74%) of them possessed plasmids. Of the 17 isolates that possessed plasmids, 11 (64.7%) of them harboured IncFIA plasmid replicon type, while 6 (35.3%), 5 (29.4%) and 5 (29.4%) were of the IncFIB, IncF and IncW types, respectively. The intI1 gene was detected in 19 (50%) of the isolates. The blaNDM-A, blaNDM-B and blaVIM genes were detected in 14 (35.9%), 4 (10.3%) and 5 (12.8%) of the isolates, respectively.</p><p><strong>Conclusions: </strong>High resistance to β-lactams was observed among P. aeruginosa strains of clinical origin in this study. They possessed transmissible genetic elements indicating the potential for continuous dissemination, thus continuous surveillance is advocated.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Transactions of The Royal Society of Tropical Medicine and Hygiene
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1